A recent study published in JAMA Neurology, indicates that commonly prescribed medications for diabetes and weight management including Ozempic, Wegovy, and Mounjaro, may also help protect against Alzheimer’s disease. Researchers studied nearly 400,000 adults over age 50 with type 2 diabetes and found that GLP-1 receptor agonists (GLP-1RAs) and SGLT2 inhibitors (SGLT2is) linked to a … Weight loss Drugs May Reduce Alzheimer’s Risk in People With Type 2 Diabetes Read More » To access this post, you must purchase Individual Subscriber Yearly or Enterprise Subscriber.